Fig. 1From: Towards definitive management of allergic rhinitis: best use of new and established therapiesAdapted from Senti et al. (2019) [105]Relative comparison of the dosing schedule for subcutaneous (SCIT), sublingual (SLIT), and intralymphatic (ILIT) immunotherapiesBack to article page